Citadel Advisors »

Recro Pharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $56k 159k 0.35
2023-09-30 $33k 70k 0.47
2023-06-30 $95k 86k 1.10
2023-03-31 $98k 83k 1.19
2022-12-31 $44k 29k 1.49
2022-06-30 $143k 182k 0.79
2022-03-31 $0 240k 0.00
2021-12-31 $378k 221k 1.71
2021-09-30 $629k 306k 2.06
2021-06-30 $646k 280k 2.31
2021-03-31 $511k 183k 2.79
2020-12-31 $103k 36k 2.85
2020-06-30 $65k 14k 4.58
2020-03-31 $651k 80k 8.17
2019-12-31 $1.8M 99k 18.32
2019-06-30 $142k 14k 10.14
2019-03-31 $172k 29k 5.89
2018-12-31 $97k 14k 7.08
2018-09-30 $229k 32k 7.13
2018-03-31 $126k 11k 11.04